SGEM#251: Nothing Compares to You…Because there was No Comparison Group
2 trialsTrials extracted from the podcast by Dr. Ken Milne
- 2019ANNEXA-4Anticoagulation & AntithromboticsIn352 patients with acute major bleeding on a factor Xa inhibitor,andexanet alfaachievedexcellent or good hemostasis at 12 hours in 82%, withno control group.
- 2017RE-VERSE ADAnticoagulation & AntithromboticsIn503 patients on dabigatran with uncontrolled bleeding or an urgent procedure,idarucizumabfullyreversed anticoagulation within minutes, withno comparator group.